Total Payments
$742,111
2024 Payments
$137,115
Companies
59
Transactions
1,935
Medicare Patients
14,242
Medicare Billing
$2.4M
Payment Breakdown by Category
Other$628,286 (84.7%)
Travel$48,127 (6.5%)
Food & Beverage$32,620 (4.4%)
Consulting$32,403 (4.4%)
Research$464.26 (0.1%)
Education$135.14 (0.0%)
Gifts$75.13 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $604,924 | 243 | 81.5% |
| Travel and Lodging | $48,127 | 136 | 6.5% |
| Food and Beverage | $32,620 | 1,517 | 4.4% |
| Consulting Fee | $32,403 | 12 | 4.4% |
| Honoraria | $23,363 | 9 | 3.1% |
| Unspecified | $464.26 | 6 | 0.1% |
| Education | $135.14 | 11 | 0.0% |
| Gift | $75.13 | 1 | 0.0% |
Payments by Type
General
$741,647
1,929 transactions
Research
$464.26
6 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $167,519 | 421 | $0 (2024) |
| Novo Nordisk Inc | $121,293 | 113 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $115,123 | 292 | $0 (2024) |
| Esperion Therapeutics, Inc. | $64,210 | 96 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $56,507 | 112 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $46,213 | 85 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $38,911 | 54 | $0 (2024) |
| Amarin Pharma Inc. | $33,209 | 78 | $0 (2022) |
| Lundbeck LLC | $27,858 | 64 | $0 (2021) |
| ARALEZ PHARMACEUTICALS US INC. | $26,924 | 39 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $137,115 | 190 | Novo Nordisk Inc ($69,195) |
| 2023 | $97,219 | 174 | Novo Nordisk Inc ($51,586) |
| 2022 | $68,889 | 267 | Janssen Pharmaceuticals, Inc ($30,756) |
| 2021 | $37,573 | 253 | Esperion Therapeutics, Inc. ($18,842) |
| 2020 | $35,310 | 175 | Amarin Pharma Inc. ($11,357) |
| 2019 | $155,807 | 318 | Janssen Pharmaceuticals, Inc ($57,059) |
| 2018 | $80,003 | 234 | Novartis Pharmaceuticals Corporation ($29,528) |
| 2017 | $130,195 | 324 | Novartis Pharmaceuticals Corporation ($62,556) |
All Payment Transactions
1,935 individual payment records from CMS Open Payments — Page 1 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/17/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Endocrinology | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: DIABETES | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 12/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Cardiology | ||||||
| 11/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,510.00 | General |
| Category: Cardio-renal | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,550.00 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.97 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Novo Nordisk Inc | Ozempic (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,938.00 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: DIABETES | ||||||
| 11/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $4.05 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| M16-100 | AbbVie, Inc. | $464.26 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 38 | 2,820 | 4,549 | $2.0M | $537,047 |
| 2022 | 45 | 3,469 | 6,066 | $2.5M | $633,110 |
| 2021 | 44 | 3,981 | 6,729 | $2.4M | $641,191 |
| 2020 | 49 | 3,972 | 6,503 | $2.3M | $614,220 |
Total Patients
14,242
Total Services
23,847
Medicare Billing
$2.4M
Procedure Codes
180
All Medicare Procedures & Services
180 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 446 | 980 | $344,960 | $82,188 | 23.8% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 139 | 139 | $301,769 | $80,503 | 26.7% |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 2023 | 60 | 120 | $93,349 | $67,304 | 72.1% |
| 78492 | Nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2023 | 95 | 95 | $253,175 | $65,941 | 26.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 231 | 236 | $124,372 | $29,902 | 24.0% |
| 36482 | Chemical destruction of first incompetent vein of arm or leg using imaging guidance | Office | 2023 | 11 | 25 | $110,150 | $29,329 | 26.6% |
| 93241 | Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 158 | 161 | $110,929 | $26,850 | 24.2% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 109 | 436 | $74,608 | $18,973 | 25.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 210 | 246 | $61,008 | $15,893 | 26.1% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 351 | $60,723 | $15,360 | 25.3% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 67 | 77 | $38,346 | $9,406 | 24.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 63 | 63 | $31,878 | $7,800 | 24.5% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 41 | 43 | $30,358 | $7,643 | 25.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 42 | 42 | $34,062 | $7,012 | 20.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $26,680 | $6,413 | 24.0% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 234 | 242 | $26,620 | $6,141 | 23.1% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 15 | $24,345 | $5,652 | 23.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 78 | 96 | $23,808 | $5,411 | 22.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 31 | 168 | $27,384 | $5,307 | 19.4% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 44 | 44 | $21,032 | $5,233 | 24.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 110 | 110 | $21,010 | $5,130 | 24.4% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 31 | 31 | $19,623 | $5,071 | 25.8% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 14 | 14 | $16,184 | $4,333 | 26.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 83 | 84 | $30,174 | $4,329 | 14.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 45 | $10,035 | $2,683 | 26.7% |
About Avichai Eres, MD FACC FSCAI FSVM
Avichai Eres, MD FACC FSCAI FSVM is a Interventional Cardiology healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740255314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Avichai Eres, MD FACC FSCAI FSVM has received a total of $742,111 in payments from pharmaceutical and medical device companies, with $137,115 received in 2024. These payments were reported across 1,935 transactions from 59 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($604,924).
As a Medicare-enrolled provider, Eres has provided services to 14,242 Medicare beneficiaries, totaling 23,847 services with total Medicare billing of $2.4M. Data is available for 4 years (2020–2023), covering 180 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Location Lexington, KY
- Active Since 02/17/2006
- Last Updated 07/23/2014
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1740255314
Products in Payments
- XARELTO (Drug) $167,803
- ENTRESTO (Drug) $114,621
- JARDIANCE (Drug) $71,760
- NEXLIZET (Drug) $61,099
- Ozempic (Drug) $55,073
- PRALUENT (Drug) $40,974
- Kerendia (Drug) $38,911
- Vascepa (Drug) $33,209
- NORTHERA (Drug) $27,858
- YOSPRALA (Drug) $15,613
- ZONTIVITY (Drug) $11,311
- PRALUENT (Biological) $4,930
- PRALUENT ALIROCUMAB INJECTION (Biological) $4,746
- NEXLETOL (Drug) $3,111
- FARXIGA (Drug) $3,037
- LOKELMA (Drug) $2,522
- LifeVest (Device) $2,396
- PRADAXA (Drug) $1,297
- MULTAQ (Drug) $804.23
- BRILINTA (Drug) $775.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Lexington
Mubashir Qazi, Md Facc Fscai, MD FACC FSCAI
Interventional Cardiology — Payments: $36,097
Interventional Cardiology $36,097
Terence Ross, Md, MD
Interventional Cardiology — Payments: $8,211
Interventional Cardiology $8,211
Madhan Shanmugasundaram, M.d, M.D
Interventional Cardiology — Payments: $3,750
Interventional Cardiology $3,750
Ms. Julie Turner, Aprn, APRN
Interventional Cardiology — Payments: $1,264
Interventional Cardiology $1,264
Kiran Saraff, M.d, M.D
Interventional Cardiology — Payments: $26.79
Interventional Cardiology $26.79